secwatch.observer — SEC 8-K summary
======================================

Issuer:     Encompass Health Corp (EHC)
CIK:        0000785161
Form:       8-K
Filed at:   2023-03-14T23:59:59+00:00
Accession:  0000785161-23-000019
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Encompass Health reiterates FY2023 guidance; Q1 rehab discharge growth strong through February
--------------------------------------------------------------------------------

- Reaffirms FY2023 net operating revenue guidance of $4.68B-$4.76B and adjusted EBITDA of $860M-$900M.
- Reaffirms adjusted EPS guidance of $2.87-$3.16.
- Inpatient rehabilitation discharge growth remained strong through February; anticipates seasonal March impact from spring break.
- CEO Mark Tarr and CFO Doug Coltharp to participate in Barclays Global Healthcare Conference on March 15.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/785161/000078516123000019/0000785161-23-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/785161/000078516123000019/ehc-20230314.htm
  HTML page:      https://secwatch.observer/filing/0000785161-23-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer